On January 12, 2026, Sanofi announced that the European Commission approved its Teizeild (teplizumab) for delaying progression to stage 3 type ...
Skilled nursing facilities (SNFs) have long been required to report ownership and managerial control information to Medicare.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果